Literature DB >> 12734504

Assessment of dermatopharmacokinetic approach in the bioequivalence determination of topical tretinoin gel products.

Lynn K Pershing1, Joel L Nelson, Judy L Corlett, Surendra P Shrivastava, Don B Hare, Vinod P Shah.   

Abstract

BACKGROUND: A new dermatopharmacokinetic (DPK) approach has been proposed for bioequivalence determination of topical drug products by comparing the drug content kinetics in stratum corneum.
OBJECTIVE: We sought to establish any correlation between clinical safety/efficacy and DPK approach in bioequivalence determination of tretinoin gel 0.025%.
METHODS: Tretinoin and isotretinoin were quantified in human volar forearm stratum corneum as a function of time with 3 tretinoin gel 0.025% products in 49 patients. Stratum corneum layers were harvested using multiple adhesive disks, which were subsequently extracted and quantified for both isomers by high-performance liquid chromatography.
RESULTS: Products with similar composition and therapeutic equivalence were found bioequivalent, and products with different composition and clinical profiles were found bioinequivalent by DPK methodology.
CONCLUSIONS: There is a direct correlation between DPK parameters in healthy patients and clinical safety/efficacy of tretinoin gel products in patients with acne. Data support the use of DPK parameters and methodology in the bioequivalence assessment of topical tretinoin gel products.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12734504     DOI: 10.1067/mjd.2003.175

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  20 in total

Review 1.  Bioequivalence for topical products--an update.

Authors:  Yogeeta Narkar
Journal:  Pharm Res       Date:  2010-09-22       Impact factor: 4.200

2.  Near infrared spectrometry for the quantification of human dermal absorption of econazole nitrate and estradiol.

Authors:  Joseph P Medendorp; Kalpana S Paudel; Robert A Lodder; Audra L Stinchcomb
Journal:  Pharm Res       Date:  2006-11-14       Impact factor: 4.200

3.  Assessment of topical bioequivalence using dermal microdialysis and tape stripping methods.

Authors:  Tuba Incecayir; Ilbeyi Agabeyoglu; Ulver Derici; Sukru Sindel
Journal:  Pharm Res       Date:  2011-04-16       Impact factor: 4.200

Review 4.  In vivo methods for the assessment of topical drug bioavailability.

Authors:  Christophe Herkenne; Ingo Alberti; Aarti Naik; Yogeshvar N Kalia; François-Xavier Mathy; Véronique Préat; Richard H Guy
Journal:  Pharm Res       Date:  2007-11-06       Impact factor: 4.200

5.  Dermatopharmacokinetics: factors influencing drug clearance from the stratum corneum.

Authors:  Sara Nicoli; Annette L Bunge; M Begoña Delgado-Charro; Richard H Guy
Journal:  Pharm Res       Date:  2008-11-25       Impact factor: 4.200

6.  Improved bioequivalence assessment of topical dermatological drug products using dermatopharmacokinetics.

Authors:  Berthe N'Dri-Stempfer; William C Navidi; Richard H Guy; Annette L Bunge
Journal:  Pharm Res       Date:  2008-10-22       Impact factor: 4.200

7.  Determining bioequivalence of topical dermatological drug products by tape-stripping.

Authors:  William Navidi; Ashlyn Hutchinson; Berthe N'Dri-Stempfer; Annette Bunge
Journal:  J Pharmacokinet Pharmacodyn       Date:  2008-05-09       Impact factor: 2.745

8.  Optimizing metrics for the assessment of bioequivalence between topical drug products.

Authors:  Berthe N'Dri-Stempfer; William C Navidi; Richard H Guy; Annette L Bunge
Journal:  Pharm Res       Date:  2008-05-01       Impact factor: 4.200

Review 9.  FDA critical path initiatives: opportunities for generic drug development.

Authors:  Robert A Lionberger
Journal:  AAPS J       Date:  2008-02-20       Impact factor: 4.009

10.  Mathematical description of the uptake of hydrocarbons in jet fuel into the stratum corneum of human volunteers.

Authors:  David Kim; Matthew W Farthing; Cass T Miller; Leena A Nylander-French
Journal:  Toxicol Lett       Date:  2008-03-16       Impact factor: 4.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.